• Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • Chlordiazepoxide, Serum
  • Candida albicans, Antigen
  • Biopsy, Bile Duct
  • Biopsy, Cervical
  • Comprehensive Mitochondrial Disorders Gene Analysis Panel, NGS (Genomic Unity®)
  • Survival of Motor Neuron 1 (SMN1) Mutation Analysis
  • Toxoplasma Gondii IgG and IgM, CSF
  • Interleukin 2 Receptor Subunit Gamma (IL2RG) Genotyping
  • Chloride, 24 Hour, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

LOINC
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.